Literature DB >> 28741454

Nanovesicular Formulations for Cancer Gene Therapy.

Lorena Tavano1, Elisabetta Mazzotta1, Rita Muzzalupo1.   

Abstract

In the last decades, gene therapy has become a novel therapeutic strategy for cancer treatment, including immunologic and molecular approaches. Among molecular avenue, the design of efficient and effective gene delivery systems, like cationic liposomes and niosomes, has been widely investigated and proposed as the most promising research area. The advantages of cationic vesicles rely on their natural ability to form complexes with anionic genetic molecules and deliver them into the cells via the endosomal pathway. Obviously, cationic vesicles- mediated gene delivery is affected by numerous factors, in particular composition, that strongly affects vesicle physical-chemistry characteristics and transfection effectiveness. This review will analyse the potential of cationic nanocarriers in cancer gene therapy, focusing on the role of liposomes and niosomes as vesicular devices and giving an exhaustive collection of the most representative investigations. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Liposomes; cancer; cationic nanocarriers.; gene therapy; liposomes; niosomes

Mesh:

Substances:

Year:  2017        PMID: 28741454     DOI: 10.2174/1381612823666170519115023

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  1 in total

1.  Delivery of the Radionuclide 131I Using Cationic Fusogenic Liposomes as Nanocarriers.

Authors:  Rejhana Kolašinac; Dirk Bier; Laura Schmitt; Andriy Yabluchanskiy; Bernd Neumaier; Rudolf Merkel; Agnes Csiszár
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.